Nationwide Geographic Access to Subcutaneous Anti-Amyloid Alzheimer Disease Therapy Infrastructure
This cross-sectional study describes how geographic availability of the minimum health care infrastructure required for subcutaneous therapy for Alzheimer disease treatment varies by age and location across the US.
Authors
- Amy J. H. Kind
- Will Buckingham
- Cassie Sanford
- Fred B. Ketchum
- W. Ryan Powell
Institutions
- University of Wisconsin–Madison (US)
Publication Details
- Journal
- JAMA Neurology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1001/jamaneurol.2026.4253
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00